TWD
NAGE

True Wealth Design’s Niagen Bioscience NAGE Stock Holding History

True Wealth Design’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$272 Sell
85
-260
-75% -$1.05K ﹤0.01% 2379
2026
Q1 		$1.52K Sell
345
-162
-32% -$875 ﹤0.01% 1650
2025
Q4 		$3.23K Sell
507
-156
-24% -$1.08K ﹤0.01% 1264
2025
Q3 		$6.19K Buy
663
+70
+12% +$707 ﹤0.01% 999
2025
Q2 		$8.55K Buy
593
+518
+691% +$5.12K ﹤0.01% 633
2025
Q1 		$518 Buy
+75
New +$471 ﹤0.01% 1527

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

True Wealth Design's NAGE Position: Q2 2026 in Review

True Wealth Design reduced its Niagen Bioscience (NAGE) stake by 75% in Q2 2026, selling an estimated $1.05K and leaving 85 shares worth $272. The position accounts for ﹤0.01% of the portfolio, ranked #2379.

True Wealth Design first reported a position in NAGE in Q1 2025 and has held it in 6 quarters since. The position peaked at $8.55K in Q2 2025. 140 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • True Wealth Design held 85 shares of Niagen Bioscience worth $272 as of Q2 2026.
  • True Wealth Design sold 260 Niagen Bioscience shares in Q2 2026, an estimated $1.05K.
  • Niagen Bioscience made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #2379 holding.
  • True Wealth Design first reported a position in Niagen Bioscience in Q1 2025 and has held it in 6 quarters since.
  • True Wealth Design's Niagen Bioscience position peaked at $8.55K in Q2 2025.
  • 140 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.